Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

220
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
220
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

233
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
233
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

289
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
289
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

311
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
311
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

236
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
236
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

371
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
371

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interventions for BK virus infection in kidney transplant recipients.

The Cochrane database of systematic reviews·2024
Same author

Rare SH2B3 coding variants in lupus patients impair B cell tolerance and predispose to autoimmunity.

The Journal of experimental medicine·2024
Same author

Safety and efficacy of biological agents in the treatment of Systemic Lupus Erythematosus (SLE).

BMC rheumatology·2023
Same author

TLR7 gain-of-function genetic variation causes human lupus.

Nature·2022
Same author

Deletions in <i>VANGL1</i> are a risk factor for antibody-mediated kidney disease.

Cell reports. Medicine·2022
Same author

Increased burden of rare variants in genes of the endosomal Toll-like receptor pathway in patients with systemic lupus erythematosus.

Lupus·2021

Related Experiment Video

Updated: Dec 31, 2025

Intravascular Delivery of Biologics to the Rat Kidney
07:29

Intravascular Delivery of Biologics to the Rat Kidney

Published on: September 1, 2016

8.0K

Interventions for renal vasculitis in adults.

Giles D Walters1, Narelle S Willis2,3, Tess E Cooper3

  • 1The Canberra Hospital, Department of Renal Medicine, Yamba Drive, Canberra, ACT, Australia, 2605.

The Cochrane Database of Systematic Reviews
|January 14, 2020
PubMed
Summary

This review of renal vasculitis treatments found plasma exchange may reduce dialysis needs but increase infections. While cyclophosphamide is standard, rituximab and mycophenolate mofetil show promise for induction, and azathioprine, methotrexate, and leflunomide for maintenance.

More Related Videos

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
09:02

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion

Published on: February 2, 2021

4.8K
Use of a Hanging-weight System for Isolated Renal Artery Occlusion
07:54

Use of a Hanging-weight System for Isolated Renal Artery Occlusion

Published on: July 19, 2011

16.4K

Related Experiment Videos

Last Updated: Dec 31, 2025

Intravascular Delivery of Biologics to the Rat Kidney
07:29

Intravascular Delivery of Biologics to the Rat Kidney

Published on: September 1, 2016

8.0K
A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
09:02

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion

Published on: February 2, 2021

4.8K
Use of a Hanging-weight System for Isolated Renal Artery Occlusion
07:54

Use of a Hanging-weight System for Isolated Renal Artery Occlusion

Published on: July 19, 2011

16.4K

Area of Science:

  • Nephrology
  • Immunology
  • Rheumatology

Background:

  • Renal vasculitis causes acute kidney injury (AKI), hematuria, and proteinuria.
  • Treatment involves steroids, non-steroids, and plasma exchange.
  • Optimal dosing, duration, and new therapies require further investigation.

Purpose of the Study:

  • To evaluate benefits and harms of interventions for adult renal vasculitis treatment.

Main Methods:

  • Searched Cochrane Kidney and Transplant Register up to November 2019.
  • Included randomized controlled trials (RCTs) of any intervention for adult renal vasculitis.
  • Analyzed data using random effects models, expressing results as risk ratios or mean differences.

Main Results:

  • Forty studies (3764 patients) were included, with quality improving over time.
  • Plasma exchange may reduce dialysis needs but increase serious infections (low certainty evidence).
  • Pulse cyclophosphamide (CPA) showed equivalent remission rates to continuous CPA but higher relapse risk; lower dose steroids may be safer.

Conclusions:

  • Plasma exchange is effective for severe AKI due to vasculitis.
  • Rituximab and mycophenolate mofetil (MMF) are effective induction therapies; azathioprine (AZA), methotrexate, and leflunomide are effective maintenance therapies.
  • Further research is needed to define the role of newer agents in evidence-based treatment strategies.